Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064467 · ClinicalTrials.gov registry record · Phase 3
Lethargic Depression Study
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 268
- Enrollment target
NCT00064467: Completed Phase 3 study, sponsored by GlaxoSmithKline.
NCT00064467 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 268 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00064467, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 268 participants
- Enrollment target
Study Summary
This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.
Interventions
- DRUG Extended-release bupropion (HCl)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-05 |
| Phase | Phase 3 |
What the finished NCT00064467 record still lists
NCT00064467 is an interventional study that assigns participants to a tested intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which Extended-release bupropion (HCl) is the first listed.
NCT00064467 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00064467 about?
NCT00064467 is a clinical study titled "Lethargic Depression Study". This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.
What is the current status of trial NCT00064467?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 268 participants. The study started on 2003-06. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00064467?
The interventions under investigation include: Extended-release bupropion (HCl) (DRUG).
Who is sponsoring clinical trial NCT00064467?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00064467's enrollment target sits among peer trials
268 1222nd of 2000 higher than 779 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- NCT05997381 · 268 participants · NA
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
- NCT06233461 · 268 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia